The Quantification of Minimal Residual Disease Pre‐ and Post‐Unmanipulated Haploidentical Allograft by Multiparameter Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Quantification of Minimal Residual Disease Pre‐ and Post‐Unmanipulated Haploidentical Allograft by Multiparameter Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia

Published:2019-08-19 Issue:1 Volume:98 Page:75-87
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Wang Xin‐Yu¹,Fan Qiao‐Zhen¹,Xu Lan‐Ping¹,Wang Yu¹,Zhang Xiao‐Hui¹,Chen Huan¹,Chen Yu‐Hong¹,Wang Feng‐Rong¹,Han Wei¹,Sun Yu‐Qian¹,Yan Chen‐Hua¹,Tang Fei‐Fei¹,Liu Yan‐Rong¹,Mo Xiao‐Dong¹,Liu Kai‐Yan¹,Huang Xiao‐Jun¹²,Chang Ying‐Jun¹^ORCID

Affiliation:

1. Peking University People's Hospital & Peking University Institute of HematologyBeijing Key Laboratory of Hematopoietic Stem Cell Transplantation Beijing People's Republic of China

2. National Clinical Research Center for Hematologic Disease Beijing People's Republic of China

Funder

Beijing Municipal Science and Technology Project

The Key Program of National Natural Science Foundation of China

The National Key Research and Development Program of China

The National Natural Science Foundation of China

The Scientific Research Foundation for Capital Medicine Development

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.21840

Reference50 articles.

1. Recent Advances in Adult Acute Lymphoblastic Leukemia

2. Description and prognostic significance of the kinetics of minimal residual disease status in adults with acute lymphoblastic leukemia treated with HyperCVAD

3. Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value

4. Minimal Residual Disease Testing in Acute Leukemia by Flow Cytometry Immunophenotyping: Prognostic Significance

5. Minimal Residual Disease Status Before Allogeneic Bone Marrow Transplantation Is an Important Determinant of Successful Outcome for Children and Adolescents With Acute Lymphoblastic Leukemia

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for positive post-transplantation measurable residual disease in patients with acute lymphoblastic leukemia;Chinese Medical Journal;2024-07-09

2. Outcome and Prognostic Factors of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory ETV6/RUNX1-Positive Acute Lymphoblastic Leukemia;Acta Haematologica;2024-01-20

3. Haploidentical hematopoietic stem cell transplantation as promising therapy in the improved survival of pediatric patients with leukemias and myelodysplasias;World Journal of Meta-Analysis;2023-06-18

4. Effects of isolated central nervous system involvement evaluated by multiparameter flow cytometry prior to allografting on outcomes of patients with acute lymphoblastic leukemia;Frontiers in Oncology;2023-05-10

5. Immunophenotypic measurable residual disease monitoring in adult acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation;Frontiers in Oncology;2023-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3